Ching Lau, M.D., Ph.D. is an Associate Professor of Pediatrics at Baylor College of Medicine (BCM), and Co-Leader of the Pediatrics Program of the Dan L. Duncan Cancer Center at BCM. Dr. Lau graduated from Rice University with a B.A. in Chemistry and subsequently received his Ph.D. in Pharmacology and M.D. from Harvard Medical School. He was a post-doctoral fellow in Cancer Genetics at Dana-Farber Cancer Center. Pediatrics Residency and Pediatric He completed his Hematology-Oncology Fellowship at Texas Children’s Hospital, Baylor College of Medicine. He is currently the Associate Director of the Pediatric Neuro-oncology Program and the Director of the Cancer Genomics Program at the Texas Children’s Cancer Center. He is a member of the Bioinformatics Steering Committee and Biopathology and Translational Research Committee of the Children’s Oncology Group. He is also a member of the Steering Committee of the Gulf Coast Consortium in Bioinformatics as well as the Executive Committee of the Structural and Computational Biology and Molecular Biophysics (SCBMB) Program, Baylor College of Medicine. His research interests include the molecular biology of pediatric brain and bone tumors and the clinical applications of genomic technologies. He is experienced in leading NCI-funded multi-disciplinary teams of research including being the principal investigator of the Director’s Challenge Project on osteosarcoma and the COG project on genome-based prognostic markers of ependymoma as well as co-principal investigator of the project on the molecular taxonomy of medulloblastoma and a member of the Steering Committee of the NCI’s Strategic Partnering to Evaluate Cancer Signatures (SPECS) Program and the NCI Therapeutically Applicable Research to Generate Effective Treatments (TARGET) Consortium. Dr. Lau has published more than 100 papers in prestigious peer-reviewed journals on cancer genetics and genomics and is a highly sought after speaker who has given more than 100 invited lectures in international and national meetings.